[ad_1]
The US Food and Drug Administration (FDA) has approved the first drug in the world that can treat cancer from its source in adults and children. Vitrakvi relies on the treatment of genetic mutations of tumors cancerous, regardless of the type or location of the disease.
"The certification of the release and introduction of this drug is an important step in the treatment of cancer because it treats it from its source and treats the base of cancer tumor genes, regardless of location their origin in the human body, "said Scott Gottlieb, Commissioner of the US Agency.
Gottlieb has confirmed that this new drug will help cancer patients get the right treatment. Vitracave helps treat people with different cancers, but their genetic mutations are common.
"Traditionally, cancer was treated on the basis of the source of cancer, but now the treatment will be applied anywhere in the body because you are treating the original gene that caused the tumor," said David Hayman, president of the Center for Early Drug Development at the Mimoreal Sloan Kettering Cancer Center, based in New York.
The drug has actually been tested on humans and a child was cured a few months after taking it: the drug will be administered on two bodies, the first in the form of tablets or capsules and the other in the form of a drug for children.
Source link
